Paediatrics Search
Paediatrics Paediatrics
neonatal%20jaundice
NEONATAL JAUNDICE
Jaundice that appears in a newborn <24 hour old is most likely nonphysiologic and needs further evaluation.
Jaundice typically presents on the 2nd-3rd day of life. It is usually first seen on the face and forehead then progresses caudally to the trunk and extremities.
Visible jaundice in the feet may be an indication to check bilirubin level.
Visual estimation of bilirubin level is often inaccurate and unreliable.
Danger signs in a newborn infant with jaundice includes changes in brainstem evoked auditory potentials, changes in muscle tone, seizures and altered cry characteristics.
The presence of any of the danger signs require prompt attention to prevent kernicterus.

Neonatal Jaundice Drug Information

Drug Information

Indication: Restoration & maintenance of circulating blood vol.

Indication: Shock, burns, hypoproteinaemia, hyperbilirubinaemia, cardiopulmonary bypass procedures.

Indication: Albumin deficiency therapy. Increase oncotic pressure in case of oncotic deficiency. Iso-oncotic vol replaceme...

Indication: Hypovolemic shock, hyperbilirubinemia, acute nephrosis, cardiopulmonary bypass procedures.

Indication: Short-term treatment of insomnia; relieve anxiety, tension & apprehension; long-term anticonvulsant therap...

Indication: Emergency treatment of hypovolemic shock, burn therapy, hypoproteinemia w/ or w/o edema, adult resp distress s...

Indication: Restoration & maintenance of circulating blood vol where vol deficiency has been demonstrated.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Preventive zinc, micronutrient powders do not improve child growth
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Amoxicillin-clavulanate regimen for PBB: 4 weeks no better than 2 weeks
Roshini Claire Anthony, 28 Sep 2020

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.

Rheuma drug shows disease-modifying potential for T1D
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).